Furthermore, results from this study also revealed that blockade of Mincle-Syk/NF-κB-mediated M1 macrophage activation may be a novel molecular mechanism through which quercetin treatment improves the severity of COVID-19 patients clinically. The gene discussed is NFKB1; the disease is COVID-19.